Literature DB >> 10740671

Antithrombotic agents and the prevention of access thrombosis.

J S Kaufman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10740671     DOI： 10.1046/j.1525-139x.2000.00012.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  8 in total

1.  Thrombophilia and arteriovenous fistula survival in ESRD.

Authors:  Birgitta Salmela; Jari Hartman; Seija Peltonen; Anders Albäck; Riitta Lassila
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

2.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Authors:  Laura M Dember; Gerald J Beck; Michael Allon; James A Delmez; Bradley S Dixon; Arthur Greenberg; Jonathan Himmelfarb; Miguel A Vazquez; Jennifer J Gassman; Tom Greene; Milena K Radeva; Gregory L Braden; T Alp Ikizler; Michael V Rocco; Ingemar J Davidson; James S Kaufman; Catherine M Meyers; John W Kusek; Harold I Feldman
Journal:  JAMA       Date:  2008-05-14       Impact factor: 56.272

3.  A double-blind, randomized, placebo-controlled pilot trial to evaluate safety and efficacy of vorapaxar on arteriovenous fistula maturation.

Authors:  Christoph B Olivier; Vandana Sundaram; Glenn M Chertow; Sumana Shashidhar; Lori K McDonnell; Victoria Y Ding; Manisha Desai; Kenneth W Mahaffey; Matthew Mell
Journal:  J Vasc Access       Date:  2019-11-27       Impact factor: 2.283

4.  The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.

Authors:  Andrea K Viecelli; Elaine Pascoe; Kevan R Polkinghorne; Carmel Hawley; Peta-Anne Paul-Brent; Sunil V Badve; Alan Cass; Stephane Heritier; Peter G Kerr; Trevor A Mori; Amanda Robertson; Hooi L Seong; Ashley B Irish
Journal:  BMC Nephrol       Date:  2015-06-27       Impact factor: 2.388

5.  The Effect of Antiplatelet Drugs on the Patency Rate of Arterio-venous Fistulae in Hemodialysis Patients.

Authors:  Mohsen Rouzrokh; Mohammad Reza Abbasi; Ali Reza Mirshemirani; Mohammad Reza Sobhiyeh
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

Review 6.  Vascular access for hemodialysis: current perspectives.

Authors:  Domenico Santoro; Filippo Benedetto; Placido Mondello; Narayana Pipitò; David Barillà; Francesco Spinelli; Carlo Alberto Ricciardi; Valeria Cernaro; Michele Buemi
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-07-08

7.  Oral prostacycline analog and clopidogrel combination provides early maturation and long-term survival after arteriovenous fistula creation: A randomized controlled study.

Authors:  A F Abacilar; H Atalay; O F Dogan
Journal:  Indian J Nephrol       Date:  2015 May-Jun

8.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.